Art

J-GLOBAL ID：200902213718536303   Reference number：06A0818154

Personalized peptide vaccines: A new therapeutic modality for cancer

個別化ペプチドワクチン 癌の新規治療法

Author (2)： ITOH Kyogo (Kurume Univ. School of Medicine) ,  YAMADA Akira (Kurume Univ. Res. Center for Innovative Cancer Therapy, Fukuoka, JPN)
Material： Cancer Science  (Cancer Sci)
Volume： 97  Issue： 10  Page： 970-976  Publication year： Oct. 2006 
JST Material Number： W1423A  ISSN： 1347-9032  Document type： Article
Article type： 文献レビュー  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： *tumor ,...
Semi thesaurus term： *personalized medicine ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=06A0818154&from=J-GLOBAL&jstjournalNo=W1423A") }}

JST classification (2)： Clinical application of immunotherapeutic agents and blood preparations  (GW22020O) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Reference (27)：

• VAN DER BRUGGEN, P. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991, 254, 1643-1647
• CHEN, YT. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA. 1997, 94, 1914-1918
• KOBAYASHI, K. Identification of a prostate-specific membrane antigen-derived peptide capable of eliciting both cellular and humoral immune responses in HLA-A24^+ prostate cancer patients. Cancer Sci. 2003, 94, 622-627
• ROSENBERG, SA. Cancer immunotherapy : moving beyond current vaccines. Nat Med. 2004, 10, 909-915
• HIDA, N. A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulation. Cancer Immunol Immunother. 2002, 51, 219-228

Terms in the title (3)： ペプチドワクチン ,  癌 ,  治療法